(Q44444375)

3 December 2017

title

Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation (English)

1 reference

3 December 2017

Pharmacokinetics of an Everolimus-Cyclosporine Immunosuppressive Regimen Over the First 6 Months After Kidney Transplantation (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00107.X

3 January 2024

1 reference

Bruce Kaplan

2

1 reference

3 December 2017

Hélio Tedesco Silva

3

1 reference

3 December 2017

Jacques Dantal

5

1 reference

3 December 2017

Louis McMahon

6

1 reference

3 December 2017

Stephane Berthier

7

1 reference

3 December 2017

Chyi-Hung Hsu

8

1 reference

3 December 2017

Christiane Rordorf

9

1 reference

3 December 2017

John M. Kovarik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752317

3 January 2024

Barry D. Kahan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752317

3 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1034/j.1600-6143.2003.00107.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752317

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-6143.2003.00107.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00107.X

https://api.elsevier.com/content/article/PII:S1600613522073051?httpAccept=text/xml

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00107.X

https://api.elsevier.com/content/article/PII:S1600613522073051?httpAccept=text/plain

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00107.X

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-6143.2003.00107.x/fullpdf

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00107.X

American Journal of Transplantation

3 January 2024

published in

1 reference

3 December 2017

volume

3

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

606-613

1 reference

Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

Long-term pharmacokinetics of the metabolites of everolimus and cyclosporine in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

inferred from DOI database lookup

7 January 2021

based on heuristic

A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00107.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

1 reference

3 December 2017

1 reference